Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Schultz IJ"'
Autor:
Schultz, Ij, Lambertus Kiemeney, Witjes, Ja, Schalken, Ja, Willems, Jl, Swinkels, Dw, Kok, Jb
Publikováno v:
Anticancer Research, 23, 3327-31
Anticancer Research, 23, 4, pp. 3327-31
ResearcherID
Anticancer Research, 23, 4, pp. 3327-31
ResearcherID
Item does not contain fulltext BACKGROUND: Expression of the inhibitor of apoptosis protein survivin is up-regulated in many tumors of epithelial origin and frequently shows a relationship with disease prognosis. MATERIALS AND METHODS: We investigate
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Coelingh Bennink HJT; Pantarhei Oncology, 3700 AL Zeist, The Netherlands., Roos EPM; Department of Urology, Antonius Hospital, 8601 ZK Sneek, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam UMC, Free University, 1081 HV Amsterdam, The Netherlands., van Melick HHE; Department of Urology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, 6532 SZ Nijmegen, The Netherlands., Roeleveld TA; Department of Urology, North-West Hospital, 1815 JD Alkmaar, The Netherlands., de Haan TD; Department of Urology, Isala Hospital, 8025 AB Zwolle, The Netherlands., Reisman Y; Flare-Health, 1012 DA Amsterdam, The Netherlands., Schultz IJ; Pantarhei Oncology, 3700 AL Zeist, The Netherlands., Krijgh J; Pantarhei Oncology, 3700 AL Zeist, The Netherlands., Debruyne FMJ; Andros Clinics, 6803 AA Arnhem, The Netherlands.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2024 Oct 08; Vol. 13 (19). Date of Electronic Publication: 2024 Oct 08.
Autor:
Schultz IJ; Pantarhei Oncology BV, Zeist, Netherlands., Zimmerman Y; Pantarhei Oncology BV, Zeist, Netherlands., Moelans CB; Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands., Chrusciel M; Institute of Biomedicine, University of Turku, Turku, Finland., Krijgh J; Pantarhei Oncology BV, Zeist, Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands., Huhtaniemi IT; Institute of Biomedicine, University of Turku, Turku, Finland.; Institute of Reproductive and Developmental Biology, Imperial College London, London, United Kingdom., Coelingh Bennink HJT; Pantarhei Oncology BV, Zeist, Netherlands.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Dec 06; Vol. 13, pp. 1233039. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
Autor:
Coelingh Bennink HJT; Pantarhei Bioscience BV, P.O. Box 464, 3700 AL, Zeist, The Netherlands. hcb@pantarheibio.com., Schultz IJ; Pantarhei Bioscience BV, P.O. Box 464, 3700 AL, Zeist, The Netherlands., Schmidt M; Department of Obstetrics and Gynaecology, University Medical Center Mainz, Mainz, Germany., Jordan VC; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Briggs P; Sexual and Reproductive Health, Liverpool Women's NHS Foundation Trust, Liverpool, UK., Egberts JFM; Terminal 4 Communications, Hilversum, The Netherlands., Gemzell-Danielsson K; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Kiesel L; Department of Gynaecology and Obstetrics, University of Münster, Münster, Germany., Kluivers K; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands., Krijgh J; Pantarhei Bioscience BV, P.O. Box 464, 3700 AL, Zeist, The Netherlands., Simoncini T; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Stanczyk FZ; Department of Obstetrics and Gynaecology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA., Langer RD; Department of Family Medicine and Public Health, University of California San Diego School of Medicine, San Diego, CA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 May 30; Vol. 25 (1), pp. 60. Date of Electronic Publication: 2023 May 30.
Autor:
Coelingh Bennink HJT; Pantarhei Oncology, Zeist, The Netherlands., Krijgh J; Pantarhei Oncology, Zeist, The Netherlands., Egberts JFM; Terminal 4 Communications, Hilversum, The Netherlands., Slootweg M; Independent Consultant, Zeist, The Netherlands., van Melick HHE; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands., Roos EPM; Department of Urology, Antonius Hospital, Sneek, The Netherlands., Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Zimmerman Y; Pantarhei Oncology, Zeist, The Netherlands., Schultz IJ; Pantarhei Oncology, Zeist, The Netherlands., Clarke NW; The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK., van Moorselaar RJA; Department of Urology, Amsterdam UMC, VU University, Amsterdam, The Netherlands., Debruyne FMJ; Andros Clinics, Arnhem, The Netherlands.
Publikováno v:
Endocrine connections [Endocr Connect] 2022 Nov 18; Vol. 11 (12). Date of Electronic Publication: 2022 Nov 18 (Print Publication: 2022).
Autor:
Schultz IJ; Pantarhei Oncology B.V., Boulevard 17, 3707BK, Zeist, The Netherlands. ijs@pantarheioncology.nl., Coelingh Bennink HJT; Pantarhei Oncology B.V., Boulevard 17, 3707BK, Zeist, The Netherlands.
Publikováno v:
Communications biology [Commun Biol] 2022 Aug 19; Vol. 5 (1), pp. 835. Date of Electronic Publication: 2022 Aug 19.